[e-drug] WHO - Advanced Technical Briefing Seminar (TBS) on Quality & Safety

E-drug: WHO - Advanced Technical Briefing Seminar (TBS) on Quality & Safety
---------------------------------------------------------------------------

The Department of Essential Medicines and Pharmaceutical Policies(HSS/EMP) of the World Health Organization will organize an Advanced Technical Briefing Seminar (TBS) on Quality and Safety of Medicines, to be held from 12-16 September 2001, at the WHO Headquarters in Geneva, Switzerland.
The general objective of this Seminar is to advance collaboration between WHO and other stakeholders from governmental and non-governmental organizations engaged in promoting the quality and safety of medicines in the global community.

The programme has been developed to increase awareness and knowledge of quality assurance and safety of medicines, blood products and related biologicals with a special focus on WHO standard-setting processes. Presentations, briefing and discussion topics will include :

* WHO development of guidelines, pharmacopoeial monographs and information resources;
* collaborative approaches underpinning classification systems (International nonproprietary names, Anatomical Therapeutic Chemical (ATC) Classification;
* quality assurance of medicines, blood products and related biologicals;
* WHO prequalification project activities;
* WHO global pharmacovigilance programme;
* WHO input to international control of narcotic and psychotropic substances

The technical briefing will be of interest to technical officers, WHO Representatives, regional advisers and country office staff of WHO and other UN agencies, national and regional drug regulators, and government and non-government officials working in related areas.

Attendance is limited to 25 places. Participation is free of charge. However, each participant is responsible for own travel and accommodation costs.
The closing date for the submission of applications is 30 June 2011. Interested persons can apply using the electronic application form, which is available at: http://www.who.int/medicines/technical_briefing/quality/en/index.html

Samvel Azatyan M.D., Ph.D. | Manager, Medicines Regulatory Support Programme [MRS]
Quality Assurance and Safety: Medicines
Department of Essential Medicines and Pharmaceutical Policies (EMP)
World Health Organization
20, Avenue Appia, CH-1211, Geneva 27, Switzerland
Direct phone: +41 22 791 1506 | Fax: +4122 791 4167
E-mail: azatyans@who.int <mailto:azatyans@who.int>
Skype: WHOHQGVA1 - then dial 11506
BlackBerry PIN: 2206EB6D
http://www.who.int/medicines/en/

E-drug: WHO - ATBS on Quality & Safety (repost with corrected date)
------------------------------------------------------------------

[Thanks to those who pointed out the date typo in the earlier message - 2001 changed to 2011 - DB]

The Department of Essential Medicines and Pharmaceutical Policies(HSS/EMP)
of the World Health Organization will organize an Advanced Technical
Briefing Seminar (TBS) on Quality and Safety of Medicines, to be held from
12-16 September 2011, at the WHO Headquarters in Geneva, Switzerland.
The general objective of this Seminar is to advance collaboration between
WHO and other stakeholders from governmental and non-governmental
organizations engaged in promoting the quality and safety of medicines in
the global community.

The programme has been developed to increase awareness and knowledge of
quality assurance and safety of medicines, blood products and related
biologicals with a special focus on WHO standard-setting processes.
Presentations, briefing and discussion topics will include :

* WHO development of guidelines, pharmacopoeial monographs and
information resources;
* collaborative approaches underpinning classification systems
(International nonproprietary names, Anatomical Therapeutic Chemical (ATC)
Classification;
* quality assurance of medicines, blood products and related
biologicals;
* WHO prequalification project activities;
* WHO global pharmacovigilance programme;
* WHO input to international control of narcotic and psychotropic
substances

The technical briefing will be of interest to technical officers, WHO
Representatives, regional advisers and country office staff of WHO and other
UN agencies, national and regional drug regulators, and government and
non-government officials working in related areas.

Attendance is limited to 25 places. Participation is free of charge.
However, each participant is responsible for own travel and accommodation
costs.
The closing date for the submission of applications is 30 June 2011